Un problema común y costoso | 13 OCT 14

Incontinencia urinaria en la mujer

Se describen los tipos más comunes de la incontinencia urinaria, las investigaciones clínicas apropiadas y las opciones terapéuticas disponibles.
2
21
Autor/a: Lauren N Wood , ! Jennifer T Anger Fuente: BMJU:204349:f4531. Urinary incontinence in women
INDICE:  1. Desarrollo | 2. Referencias
Referencias
  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology2003;61:37-49.
  2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J2010;21:5-26.
  3. Norton P, Brubaker L. Urinary incontinence in women. Lancet2006;367:57-67.
  4. Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc1998;46:473-80.
  5. Branch LG, Walker LA, Wetle TT, DuBeau CE, Resnick NM. Urinary incontinence knowledge among community-dwelling people 65 years of age and older. J Am Geriatr Soc1994;42:1257-62.
  6. Cheater FM, Castleden CM. Epidemiology and classification of urinary incontinence. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:183-205.
  7. Hunskaar S, Arnold EP, Burgio K, et al. Epidemiology and natural history of urinary incontinence. In: Abrams P, Khoury S, Wein A, eds. Incontinence—first international consultation on incontinence. Plymbridge Distributors, 1999:199-226.
  8. Nygaard IE, Heit M. Stress urinary incontinence. Obstet Gynecol2004;104:607-20.
  9. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol2003;20:327-36.
  10. Anger JT, Saigal CS, Madison R, Joyce G, Litwin MS, Urologic Diseases of America Project. Increasing costs of urinary incontinence among female Medicare beneficiaries. J Urol2006;176:247-51; discussion 51.
  11. Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc1991;39:378-82.
  12. Melville JL, Delaney K, Newton K, Katon W. Incontinence severity and major depression in incontinent women. Obstet Gynecol2005;106:585-92.
  13. Nygaard I, Turvey C, Burns TL, Crischilles E, Wallace R. Urinary incontinence and depression in middle-aged United States women. Obstet Gynecol2003;101:149-56.
  14. Brown JS, Vittinghoff E, Wyman JF, Stone KL, Nevitt MC, Ensrud KE, et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group J Am Geriatr Soc2000;48:721-5.
  15. Thom DH, Haan MN, Van Den Eeden SK. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing1997;26:367-74.
  16. Levy R, Muller N. Urinary incontinence: economic burden and new choices in pharmaceutical treatment. Adv Ther2006;23:556-73.
  17. Wilson L, Brown JS, Shin GP, Luc KO, Subak LL. Annual direct cost of urinary incontinence. Obstet Gynecol2001;98:398-406.
  18. Ganz ML, Smalarz AM, Krupski TL, Anger JT, Hu JC, Wittrup-Jensen KU, et al. Economic costs of overactive bladder in the United States. Urology2010;75:526-32, 32 e1-18.
  19. Peyrat L, Haillot O, Bruyere F, Boutin JM, Bertrand P, Lanson Y. Prevalence and risk factors of urinary incontinence in young and middle-aged women. BJU Int2002;89:61-6.
  20. Rortveit G, Daltveit AK, Hannestad YS, Hunskaar S, Norwegian ES. Urinary incontinence after vaginal delivery or cesarean section. N Engl J Med2003;348:900-7.
  21. Parazzini F, Chiaffarino F, Lavezzari M, Giambanco V, Group VS. Risk factors for stress, urge or mixed urinary incontinence in Italy. BJOG2003;110:927-33.
  22. Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a systematic review. Lancet2000;356:535-9.
  23. Samuelsson E, Victor A, Svardsudd K. Determinants of urinary incontinence in a population of young and middle-aged women. Acta Obstet Gynecol Scand2000;79:208-15.
  24. Van Oyen H, Van Oyen P. Urinary incontinence in Belgium; prevalence, correlates and psychosocial consequences. Acta Clin Belg2002;57:207-18.
  25. Zargham M, Alizadeh F, Moayednia A, Haghdani S, Nouri-Mahdavi K. The role of pelvic organs prolapse in the etiology of urinary incontinence in women. Adv Biomed Res2013;2:22.
  26. Bortolotti A, Bernardini B, Colli E, Di Benedetto P, Giocoli Nacci G, Landoni M, et al. Prevalence and risk factors for urinary incontinence in Italy. Eur Urol2000;37:30-5.
  27. Sampselle CM, Harlow SD, Skurnick J, Brubaker L, Bondarenko I. Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women. Obstet Gynecol2002;100:1230-8
  28. Hannestad YS, Lie RT, Rortveit G, Hunskaar S. Familial risk of urinary incontinence in women: population based cross sectional study. BMJ2004;329:889-91.
  29. Bump RC, McClish DK. Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol1992;167:1213-8.

  30. Fuganti PE, Gowdy JM, Santiago NC. Obesity and smoking: are they modulators of cough intravesical peak pressure in stress urinary incontinence? Int Braz J Urol2011;37:528-33.
  31. Riesenhuber A, Boehm M, Posch M, Aufricht C. Diuretic potential of energy drinks. Amino Acids2006;31:81-3.
  32. Gleason JL, Richter HE, Redden DT, Goode PS, Burgio KL, Markland AD. Caffeine and urinary incontinence in US women. Int Urogynecol J2013;24:295-302.
  33. Wein AJ, Kavoussi LR, Novick AC, Partin AM, Peters CA. Urinary incontinence and pelvic prolapse: epidemiology and pathophysiology. In: Wein AJ, ed. Campbell-Walsh urology. 10th ed. Elsevier Saunders, 2012:1871-95.
  34. Anger JT, Scott VC, Kiyosaki K, Khan AA, Weinberg A, Connor SE, et al. Development of quality indicators for women with urinary incontinence. Neurourol Urodynam2013;32:1058-63.
  35. National Institute for Health and Care Excellence. Urinary incontinence: the management of urinary incontinence in women. CG171. 2013. www.nice.org.uk/Guidance/CG171.
  36. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Continence Program for Women Research Group. Neurourol Urodynam1995;14:131-9.
  37. Avery KN, Bosch JL, Gotoh M, Naughton M, Jackson S, Radley SC, et al. Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol2007;177:39-49.
  38. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol2012;188(6 suppl):2455-63.
  39. Scientific Committee of the First International Consultation on Incontinence. Assessment and treatment of urinary incontinence. Lancet2000;355:2153-8.
  40. Fonda D, Resnick NM, Colling J, Burgio K, Ouslander JG, Norton C, et al. Outcome measures for research of lower urinary tract dysfunction in frail older people. Neurourol Urodynam1998;17:273-81.
  41. Haylen BT, Sutherst JR, Frazer MI. Is the investigation of most stress incontinence really necessary? Br J Urol1989;64:147-9.
  42. Nager CW, Brubaker L, Litman HJ, Zyczynski HM, Varner RE, Amundsen C, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med2012;366:1987-97.
  43. Van Leijsen SAL, Kluivers KB, Mol BJ, in ‘t Hout J, Milani AL, Roovers JPWR, et al. Value of urodynamics before stress urinary incontinence surgery a randomized controlled trial. Obstet Gynecol2013;121:999-1008.
  44. Khan IJ, Tariq SH. Urinary incontinence: behavioral modification therapy in older adult. Clin Geriatr Med2004;20:499-509, vii.
  45. Valtin H. “Drink at least eight glasses of water a day.” Really? Is there scientific evidence for “8 × 8”? Am J Physiol Regul Integr Comp Physiol2002;283:R993-1004.
  46. Wyman JF, Burgio KL, Newman DK. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract2009;63:1177-91.
  47. Kinnunen O. Study of constipation in a geriatric hospital, day hospital, old people’s home and at home. Aging1991;3:161-70.
  48. Wing RR, West DS, Grady D, Creasman JM, Richter HE, Myers D, et al. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol2010;184:1005-10.
  49. Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev2010;1:CD005654.
  50. Benvenuti F, Caputo GM, Bandinelli S, Mayer F, Biagini C, Sommavilla A. Reeducative treatment of female genuine stress incontinence. Am J Phys Med1987;66:155-68.
  51. Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA1998;280:1995-2000.
  52. Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ. Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev2012;1:CD005429.
  53. Erdem N, Chu FM. Management of overactive bladder and urge urinary incontinence in the elderly patient. Am J Med2006;119(3 suppl 1):29-36.
  54. Kato K, Yoshida K, Suzuki K, Murase T, Gotoh M. Managing patients with an overactive bladder and glaucoma: a questionnaire survey of Japanese urologists on the use of anticholinergics. BJU Int2005;95:98-101.
  55. Todorova A, Vonderheid-Guth B, Dimpfel W. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol2001;41:636-44.
  56. Sexton CC, Notte SM, Maroulis C, Dmochowski RR, Cardozo L, Subramanian D, et al. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract2011;65:567-85.
  57. Brostrom S, Hallas J. Persistence of antimuscarinic drug use. Eur J Clin Pharmacol2009;65:309-14.
  58. Staskin DR, Harnett MD. Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder. Curr Urol Rep2004;5:423-6.
  59. Chancellor MB, Staskin DR, Kay GG, Sandage BW, Oefelein MG, Tsao JW. Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder. Drugs Aging2012;29:259-73.
  60. Buser N, Ivic S, Kessler TM, Kessels AG, Bachmann LM. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol2012;62:1040-60.
  61. Nitti VW, Auerbach S, Martin N, Calhoun A, Lee M, Herschorn S. Results of a randomized phase III trial of mirabegron in patients with overactive bladder. J Urol2013;189:1388-95.
  62. Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodynam2014;33:17-30.
  63. Anger JT, Nissim HA, Le TX, Smith AL, Lee U, Sarkisian C, et al. Women’s experience with severe overactive bladder symptoms and treatment: insight revealed from patient focus groups. Neurourol Urodynam2011;30:1295-9.
  64. Chapple C, Sievert KD, MacDiarmid S, Khullar V, Radziszewski P, Nardo C, et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol2013;64:249-56.
  65. Anger JT, Weinberg A, Suttorp MJ, Litwin MS, Shekelle PG. Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature. J Urol2010;183:2258-64.
  66. Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol2011;60:742-50.
  67. Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol2013;189:2186-93.
  68. Chancellor MB, Elovic E, Esquenazi A, Naumann M, Segal KR, Schiavo G, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions. Toxicon2013;67:129-40.
  69. Starkman JS, Wolter CE, Scarpero HM, Milam DF, Dmochowski RR. Management of refractory urinary urge incontinence following urogynecological surgery with sacral neuromodulation. Neurourol Urodynam2007;26:29-35; discussion 6.
  70. Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol2006;175(3 pt 1):835-41.
  71. Cameron AP, Anger JT, Madison R, Saigal CS, Clemens JQ; Urologic Diseases in America Project. National trends in the usage and success of sacral nerve test stimulation. J Urol2011;185:970-5.
  72. Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol2009;182(3):1055-61.
  73. MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol2010;183:234-40.
  74. Levin PJ, Wu JM, Kawasaki A, Weidner AC, Amundsen CL. The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review. Int Urogynecol J2012;23:1591-7.
  75. Li J, Yang L, Pu C, Tang Y, Yun H, Han P. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int Urol Nephrol2013;45:679-86.
  76. Richter HE, Burgio KL, Brubaker L, Nygaard IE, Ye W, Weidner A, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol2010;115:609-17
  77. Dmochowski RR, Blaivas JM, Gormley EA, Juma S, Karram MM, Lightner DJ, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol2010;183:1906-14.
  78. Maher CF, O’Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P. Pubovaginal sling versus transurethral macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG 2005;112:797-801.
  79. Keegan PE, Atiemo K, Cody J, McClinton S, Pickard R. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev2007;3:CD003881.
  80. Lee HN, Lee YS, Han JY, Jeong JY, Choo MS, Lee KS. Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures. Int Urogynecol J2010;21:1479-83.
  81. Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med2007;356:2143-55.
  82. Brubaker L, Richter HE, Norton PA, Albo M, Zyczynski HM, Chai TC, et al. 5-year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence. J Urol2012;187:1324-30.
  83. Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev2009;4:CD006375.
  84. DeLancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol1994;170:1713-20; discussion 20-3.
  85. Petros PE, Ulmsten UI. An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta Obstetric Gynecol Scand Suppl1990;153:7-31.
  86. Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med2010;362:2066-76.
  87. Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo KJ, Lloyd KL, et al. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol2011;205:498 e1-6.
  88. Novara G, Ficarra V, Boscolo-Berto R, Secco S, Cavalleri S, Artibani W. Tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials of effectiveness. Eur Urol2007;52:663-78.
  89. Latthe PM, Foon R, Toozs-Hobson P. Transobturator and retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG2007;114:522-31.
  90. Nilsson CG, Palva K, Rezapour M, Falconer C. Eleven years prospective follow-up of the tension-free vaginal tape procedure for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct2008;19:1043-7.
  91. Schimpf MO, Rahn DD, Wheeler TL, Patel M, White AB, Orejuela FJ, et al. Sling surgery for stress urinary incontinence in women: a systematic review and metaanalysis. Am J Ostet Gynecol2014;211:71.e1-71.e27.
  92. Abdel-Fattah M, Ford JA, Lim CP, Madhuvrata P. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: a meta-analysis of effectiveness and complications. Eur Urol2011;60:468-80.
  93. Min LC, Reuben DB, Adams J, Shekelle PG, Ganz DA, Roth CP, et al. Does better quality of care for falls and urinary incontinence result in better participant-reported outcomes? J Am Geriatr Soc2011;59:1435-43.
 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2020